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In recent years, pyrazolopyrimidines and related fused hetero-
cycles have been identiﬁed as bioactive molecules. They are known to
function as CNS (Central Nervous System) depressants, neuroleptic
agents, and as tuberculostatic. Pyrazolo[3,4-d]pyrimidines were
identiﬁed as a general class of adenosine receptors. The aim of this
work was to determine the antioxidant properties of some novel
pyrazolo[3,4-d]pyrimidine derivatives once oxidative stress is thought
to play an important role in numerous degenerative or chronic
diseases, such as atherosclerosis and cancer. Our results show that
some of these compounds have good antioxidant when using ABTS
and DPPH methods. Furthermore, membrane protection against tert-
butylhydroperoxide oxidation was observed by the decrease in the
TBARS produced when mitochondrial membranes were pretreated
with those compounds. We also evaluate their effect onmitochondrial
bioenergetics. State 4, state 3 respiration, and mitochondrial mem-
brane potential will be studied in the presence of themore antioxidant
efﬁcient compounds.
doi:10.1016/j.bbabio.2008.05.243
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Ubiquinone or plasoquinone conjugated via decane linker with
triphenyl phosphonium cation (MitoQ and SkQ1, respectively) are
shown to be powerful antioxidants in isolated mitochondria. We
found that plastoquinone conjugated with positively charged ﬂuor-
ophore rhodamine-19 (SkQR1) selectively accumulates in mitochon-
dria of HeLa cells and human ﬁbroblasts, reaching plateau at 2 h.
Uncoupler FCCP suppresses the accumulation and stimulates the
release of SkQR1. Incubation with nanomolar SkQ1 or SkQR1 for 2 h
prevents oxidation of glutathione and fragmentation of mitochondria
induced byH2O2. However, 2 h incubation does not result in resistance
of HeLa cells and human ﬁbroblasts to H2O2 or other prooxidants
(menadione, paraquat). The protective effect becomes pronounced
only after 24 h incubation and disappeares during 48 h after removal
of quinones in parallel with SkQR1 release from the cells. Prolonged
(6–7 d) incubation with 1–20 nM SkQ1 causes strong resistance
against oxidative stress, MitoQ being 100 times less effective.
Simultaneously, the antioxidants promote structural and functional
fusion of mitochondria increasing the size of electrically-united
mitochondrial network. Staining of mitochondria with SkQR1 for 2 h
revealed their signiﬁcant heterogeneity while after prolonged
incubation mitochondria become uniformly stained. It is suggested
that slow development of the antiapoptotic effect is related to slowredistribution of mitochondria-targeted antioxidants between mito-
chondria in the cell.
Sponsored by O. V. Deripaska.
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Addition of mitochondria-targeted coenzymeQ,MitoQ10, to HEP-G2
cells with rotenone-inhibited mitochondrial Complex I sharply
decreases rotenone-induced superoxide release to the matrix (Jm) and
increases cell respiration. Thenoyltriﬂuoroacetone, a Complex II
inhibitor, together with rotenone completely inhibited HEPG2 cell
respiration and kept high Jm, while subsequent MitoQ10 addition
restored again respiration in an antimycin- (stigmatellin- and myx-
othiazol-)-dependentmanner, but did not prevent high Jm.We conclude
that MitoQ10 is able to accept electrons prior to the rotenone-bound Q-
site and that a reversemodeofComplex II is likely required to regenerate
the reduced MitoQ10H2 back to MitoQ10. Complex III inhibitors
(antimycin, stigmatellin and myxothiazol) prevented high Jm in HEPG2
cells induced with either rotenone and MitoQ10, or with rotenone,
MitoQ10, and thenoyltriﬂuoroacetone. MitoQ10 alone increased basal Jm
in HEPG2 cells highlighting also its pro-oxidant property. Described
effects of all reagents combinationsweremore pronounced in JmHEPG2
cells compared to H2O2 formation in isolated liver mitochondria. In
conclusion, MitoQ10 possesses a pro-oxidant role when added to intact
mitochondrial respiratory chain, whereas its antioxidant role is striking
when Complex I-derived superoxide generation increases due to
retardation of electron ﬂow within the Complex I.
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We tested a hypothesis that reactive oxygen species (ROS)-
dependent activation of mitochondrial phospholipases leads to an
increase in respiration and to more intensive attenuation of
mitochondrial ROS production due to UCP2-dependent uncoupling.
This was tested using rat lung mitochondria and further veriﬁed using
lung mitochondria isolated from UCP2-WT and UCP2-KO mice.
Mitochondriawith succinate as a substrate exhibited a steady increase
in respiration which was further stimulated by low concentrations of
tert-butyl hydroperoxide (TBHP, 5–25 μM). The observed respiration
increase was fully inhibited by BSA, indicating the participation of free
fatty acids, and by bromoenol lactone (BEL, 10 μM), a speciﬁc inhibitor
of phospholipases iPLA2. The respiration was further partially
inhibited by GTP, an inhibitor of UCP2. The TBHP-dependent increase
in respiratory rate was not observed in lung mitochondria isolated
from UCP2-KO mice. Parallel detection of H2O2 by Amplex Red
revealed that neither BSA nor BEL caused a signiﬁcant increase in
mitochondrial H2O2 production under the given experimental
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mitochondria and support the hypothesis that the activation of
mitochondrial phospholipases by mild oxidative stress can provide
free fatty acids as cycling substrates for UCP2. However, attenuation of
ROS production by UCP2 is not signiﬁcant.
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We have studied the quinone structural features that confer
modulatory properties on the mitochondrial permeability transition
pore (PTP). Reduced derivatives of ubiquinone (Ub) 0 with acetoxy or
methoxy substitutions of the carbonyl groups became ineffective at
PTP inhibition. Consistent with a key role of the Ub0 oxidation-
reduction state for its interactions with the PTP, DTT prevented the
inhibitory effects on the pore when added before but not after Ub0. Of
note, the addition of DTT after Ub0 prevented the toxic effects of Ub0
on respiration. The combination of Ub0 and DTT thus allowed
inhibition of the PTP without mitochondrial toxicity, which in the
absence of DTT reveals itself with a bell-shaped curve where the Ub0-
dependent increase of mitochondrial Ca2+ retention capacity (a
measure of PTP inhibition) is superceded by a decrease as the Ub0
concentration is raised above about 50 μM. The PTP inhibitory effects
of decylUb were instead unaffected by reducing agents, and Ub0 and
decylUb displayed additive effects on PTP inhibition, indicating that
they act at different inhibitory sites on the PTP.
doi:10.1016/j.bbabio.2008.05.247
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Synthesized in the Skulachev's laboratory new type of mitochon-
dria-targeted antioxidants — plastoquinone derivatives (SkQs) were
investigated. The aim of our study was to estimate of antioxidant
properties of the SkQ family members plastoquinonyl decyltriphe-
nylphosphonium (SkQ1) and plastoquinonyl decylrhodamin 19
(SkQR1), a ﬂuorescent derivative. These compounds combined with
a positively-charged penetrating cations were selectively targeted to
mitochondria, being accumulated inside, and can be reduced by the
respiratory chain. Using confocal microscope we observed that SkQR1
was accumulated bymitochondria. Uncoupling action of FCCP, leading
to mitochondrial depolarization, prevented the SkQR1 staining. In
human cell cultures HeLa and K562 very low concentrations
(nanomolar) of antioxidants were found to prevent ROS-induced
apoptosis and necrosis. Oxidative stress initiated by addition of small
amount H2O2 to living cells, caused secondary generation of
endogenous ROS and lowered the level of reduced glutathione.SkQ1 and SkQR1 prevented oxidative damage as well as glutathione
oxidation, C1/2 being around 2nM and 0.5 nM respectively. It is
concluded that cationic plastoquinone derivatives are rechargeable,
mitochondria-targeted antioxidants of very high efﬁciency.
doi:10.1016/j.bbabio.2008.05.248
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Our aimwas to analyse the effects of VP on the production of ROS by
lymphocytes and determine the possible mitochondrial sources of
these ROS. Twelve women affected by VP and twelve control healthy
women participated in the study. H2O2 production was measured
using 2,7-dichloroﬂuorescin-diacetate as indicator in basal conditions
and after stimulation with PMA. In addition three treatments with
allopurinol, rotenone or myxothiazol were performed in PMA-
stimulated lymphocytes. No differences were observed between
porphyric and control women in the basal production of H2O2. The
stimulation with PMA increased H2O2 production in both groups but
lymphocytes from porphyric women produced higher levels of H2O2
than controls. The treatments with allopurinol and rotenone did not
modify H2O2 production but after treatment with myxothiazol H2O2
production decreased back to basal levels in both groups. In
conclusion, lymphocytes from women affected by VP produce the
same amount of H2O2 in basal conditions than control women, but
after stimulation lymphocytes from porphyric women produce higher
levels of H2O2. This increased H2O2 production is due to an impaired
function of the mitochondrial respiratory chain rather than to other
ROS sources such as xanthine oxidase.
doi:10.1016/j.bbabio.2008.05.249
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Camptothecin (CPT), a topoisomerase I inhibitor, is used for treat-
ment of certain types of malignancies. Uncoupling protein 2 (UcP2) is
proposed to protect cardiomyocytes against oxidative stress. Modula-
tion of UcP2 level appears important because the protein increases in
failing human heart. p38MAPK belongs to a group of protein serine/
threonine kinases that become activated in response to extracellular
stimuli and mediate signal transduction in cell growth, differentiation
and apoptosis. We found that CPT treatment induces UcP2 expression
on both mRNA and protein level in cardiomyocytes. This induction is
accompanied by short-term increase in production of ROS (b1 h)
preceded by activation of p38MAPK (b30 min). Activation of p38MAPK
by CPT was comparable to anisomycin, a protein synthesis inhibitor
that activates stress-related MAPKs, namely p38MAPK in mammalian
cells. Pretreatment of cardiomyocytes with p38MAPK inhibitor,
SB203580, blocked activation of p38MAPK by both compounds and
abolished the camptothecin-mediated UcP2 induction. Our results
